Authors:
El-Gamel, A
Sim, E
Hasleton, P
Hutchinson, J
Yonan, N
Egan, J
Campbell, C
Rahman, A
Sheldon, S
Deiraniya, A
Hutchinson, IV
Citation: A. El-gamel et al., Transforming growth factor beta (TGF-beta) and obliterative bronchiolitis following pulmonary transplantation, J HEART LUN, 18(9), 1999, pp. 828-837
Authors:
Stacey, M
Matas, N
Drake, M
Payton, M
Fakis, G
Greenland, J
Sim, E
Citation: M. Stacey et al., Arylamine N-acetyltransferase type 2 (NAT2), chromosome 8 aneuploidy, and identification of a novel NATI cosmid clone: An investigation in bladder cancer by interphase FISH, GENE CHROM, 25(4), 1999, pp. 376-383
Authors:
Thygesen, P
Risch, A
Stacey, M
Fakis, G
Takle, L
Knowles, M
Sim, E
Citation: P. Thygesen et al., Genes for human arylamine N-acetyltransferases in relation to loss of the short arm of chromosome 8 in bladder cancer, PHARMACOGEN, 9(1), 1999, pp. 1-8
Citation: Ab. Mongey et al., Acetylation status is associated with serological changes but not clinically significant disease in patients receiving procainamide, J RHEUMATOL, 26(8), 1999, pp. 1721-1726
Authors:
Payton, M
Auty, R
Delgoda, R
Everett, M
Sim, E
Citation: M. Payton et al., Cloning and characterization of arylamine N-acetyltransferase genes from Mycobacterium smegmatis and Mycobacterium tuberculosis: Increased expressionresults in isoniazid resistance, J BACT, 181(4), 1999, pp. 1343-1347
Citation: M. Payton et al., A method for genotyping murine arylamine N-acetyltransferase type 2 (NAT2): A gene expressed in preimplantation embryonic stem cells encoding an enzyme acetylating the folate catabolite p-aminobenzoylglutamate, BIOCH PHARM, 58(5), 1999, pp. 779-785